Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan
暂无分享,去创建一个
Ute Hamann | U. Hamann | N. Muhammad | M. U. Rashid | Asim Amin | Muhammad U Rashid | Noor Muhammad | Saima Faisal | S. Faisal | A. Amin
[1] M. Schutte,et al. Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant , 2004, Journal of Medical Genetics.
[2] J. Klijn,et al. The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families. , 2003, Cancer research.
[3] D. Horsman,et al. Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study. , 2008, Cancer research.
[4] P. Ang,et al. CHEK2*1100delC screening of Asian women with a family history of breast cancer is unwarranted. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Nazneen Rahman,et al. Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility. , 2003, American journal of human genetics.
[6] Jiri Bartek,et al. Chk1 and Chk2 kinases in checkpoint control and cancer. , 2003, Cancer cell.
[7] Kenneth Offit,et al. Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population. , 2005, Human molecular genetics.
[8] M. Papa,et al. Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer. , 2007, The Israel Medical Association journal : IMAJ.
[9] J. Klijn,et al. The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. , 2003, American journal of human genetics.
[10] Leila Mohammadi,et al. BMC Cancer , 2001 .
[11] P. Oefner,et al. Denaturing high‐performance liquid chromatography: A review , 2001, Human mutation.
[12] J. Benítez,et al. The breast cancer low‐penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population , 2004, International journal of cancer.
[13] S. Ahn,et al. The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation , 2008, Breast Cancer Research and Treatment.
[14] J. Lubiński,et al. Pathology of breast cancer in women with constitutional CHEK2 mutations , 2005, Breast Cancer Research and Treatment.
[15] J. Schleutker,et al. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals , 2011, Breast Cancer Research.
[16] Päivi Heikkilä,et al. CHEK2 variant I157T may be associated with increased breast cancer risk , 2004, International journal of cancer.
[17] U. Hamann,et al. Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients , 2006, International journal of cancer.
[18] Nazneen Rahman,et al. Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations , 2002, Nature Genetics.
[19] J. Lubiński,et al. Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer , 2012, Breast Cancer Research and Treatment.
[20] N. Soumittra,et al. BRCA1, BRCA2 and CHEK2 (1100 del C) germline mutations in hereditary breast and ovarian cancer families in South India. , 2003, Asian Pacific journal of cancer prevention : APJCP.
[21] I. Nolte,et al. Increased CHEK2 1100delC genotype frequency (also) in unselected breast cancer patients. , 2004, Journal of Clinical Oncology.
[22] S. Teo,et al. CHEK2*1100delC does not contribute to risk to breast cancer among Malay, Chinese and Indians in Malaysia , 2009, Familial Cancer.
[23] P. Souček,et al. Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterations , 2008, Breast Cancer Research and Treatment.
[24] S. Bojesen,et al. CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients , 2012, Familial Cancer.
[26] N. Mailand,et al. The ATM–Chk2–Cdc25A checkpoint pathway guards against radioresistant DNA synthesis , 2001, Nature.
[27] A. Jakubowska,et al. Estrogen receptor status in CHEK2‐positive breast cancers: implications for chemoprevention , 2009, Clinical genetics.
[28] David I. Smith,et al. Mutations in CHEK2 associated with prostate cancer risk. , 2003, American journal of human genetics.
[29] A. Hollestelle,et al. Discovering moderate-risk breast cancer susceptibility genes. , 2010, Current opinion in genetics & development.
[30] S. Narod,et al. CHEK2 mutation and hereditary breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] Jong-Soo Lee,et al. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response , 2000, Nature.
[32] T. Halazonetis,et al. Chk 2 / hCds 1 functions as a DNA damage checkpoint in G 1 by stabilizing p 53 , 2022 .
[33] Rochelle L. Garcia,et al. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing , 2011, Proceedings of the National Academy of Sciences.
[34] J. Lubiński,et al. CHEK2 is a multiorgan cancer susceptibility gene. , 2004, American journal of human genetics.
[35] S. Moreno,et al. Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1 , 1998, Nature.
[36] N. Soumittra,et al. Molecular genetics analysis of hereditary breast and ovarian cancer patients in India , 2009, Hereditary cancer in clinical practice.
[37] P. Devilee,et al. Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia , 2007, Familial Cancer.
[38] Z. Shao,et al. [CHEK2 c.1100delC may not contribute to genetic background of hereditary breast cancer from Shanghai of China]. , 2006, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.
[39] Yuntao Xie,et al. A recurrent CHEK2 p.H371Y mutation is associated with breast cancer risk in Chinese women , 2011, Human mutation.
[40] Patricia L. Harris,et al. Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts , 2007, International journal of cancer.
[41] O. Kallioniemi,et al. A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. , 2002, American journal of human genetics.
[42] T. Halazonetis,et al. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. , 2000, Genes & development.
[43] R. Eeles,et al. A robust method for detecting CHK2/RAD53 mutations in genomic DNA , 2002, Human mutation.
[44] W. Chen,et al. Breast cancer low-penetrance allele 1100delC in the CHEK2 gene: Not present in the Chinese familial breast cancer population , 2008, Advances in therapy.
[45] A. Meindl,et al. Limited relevance of the CHEK2 gene in hereditary breast cancer , 2004, International journal of cancer.
[46] J. Hopper,et al. Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study , 2011, Breast Cancer Research.
[47] A. Jakubowska,et al. A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland , 2007, Breast Cancer Research and Treatment.
[48] Nazneen Rahman,et al. CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. , 2004, American journal of human genetics.
[49] T. Walsh,et al. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. , 2006, JAMA.
[50] W. Foulkes,et al. Identification of a novel CHEK2 variant and assessment of its contribution to the risk of breast cancer in French Canadian women , 2008, BMC Cancer.
[51] T. Dörk,et al. Association of two mutations in the CHEK2 gene with breast cancer , 2005, International journal of cancer.
[52] Y. Bignon,et al. CHEK2 contribution to hereditary breast cancer in non-BRCA families , 2011, Breast Cancer Research.
[53] S. Elledge,et al. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. , 2000, Proceedings of the National Academy of Sciences of the United States of America.